positive
3h agoNephroPlus cleared by SEBI for ₹353 crore IPO to expand dialysis network across India

India’s leading dialysis chain, NephroPlus, obtained SEBI approval for its ₹353 crore initial public offering aimed at scaling its healthcare infrastructure and technology-enabled renal care. The IPO will comprise a fresh issue and offer-for-sale by existing investors. The proceeds are expected to finance the establishment of new centers and digital patient-monitoring systems. NephroPlus currently operates over 320 dialysis centers in 190 cities. Its planned listing underscores investor appetite for healthcare growth stories driven by rising demand for chronic disease management services in India’s expanding medical ecosystem.
Explore:High Return Equity Mutual Fund
positive
3h agoNephroPlus cleared by SEBI for ₹353 crore IPO to expand dialysis network across India

India’s leading dialysis chain, NephroPlus, obtained SEBI approval for its ₹353 crore initial public offering aimed at scaling its healthcare infrastructure and technology-enabled renal care. The IPO will comprise a fresh issue and offer-for-sale by existing investors. The proceeds are expected to finance the establishment of new centers and digital patient-monitoring systems. NephroPlus currently operates over 320 dialysis centers in 190 cities. Its planned listing underscores investor appetite for healthcare growth stories driven by rising demand for chronic disease management services in India’s expanding medical ecosystem.
Explore:High Return Equity Mutual Fund
Breaking
positive
NephroPlus cleared by SEBI for ₹353 crore IPO to expand dialysis network across India
about 4 hours ago
1 min read
86 words

NephroPlus gained SEBI clearance for a ₹353 crore IPO to strengthen its dialysis network and digital care capabilities across India.
India’s leading dialysis chain, NephroPlus, obtained SEBI approval for its ₹353 crore initial public offering aimed at scaling its healthcare infrastructure and technology-enabled renal care. The IPO will comprise a fresh issue and offer-for-sale by existing investors. The proceeds are expected to finance the establishment of new centers and digital patient-monitoring systems. NephroPlus currently operates over 320 dialysis centers in 190 cities. Its planned listing underscores investor appetite for healthcare growth stories driven by rising demand for chronic disease management services in India’s expanding medical ecosystem.

India’s leading dialysis chain, NephroPlus, obtained SEBI approval for its ₹353 crore initial public offering aimed at scaling its healthcare infrastructure and technology-enabled renal care. The IPO will comprise a fresh issue and offer-for-sale by existing investors. The proceeds are expected to finance the establishment of new centers and digital patient-monitoring systems. NephroPlus currently operates over 320 dialysis centers in 190 cities. Its planned listing underscores investor appetite for healthcare growth stories driven by rising demand for chronic disease management services in India’s expanding medical ecosystem.
Companies:
NephroPlus
Tags:
ipo
healthcare
ipo
healthcare
nephroplus
sebi
dialysis
Nov 10, 2025 • 21:08 IST